论文部分内容阅读
食管癌患者经多年的外科治疗经验表明,单用外科治疗不可能治愈,难以保证不复发转移,改善外科技术和扩大手术范围也不能改善远期疗效。本文旨在对食管癌的综合治疗的近期和远期疗效作一评价。 研究对象为268例经根治性手术的食管癌患者,其中男188例(70.2％)、女80例(29.8％),年龄为31～72岁。采取术前放疗114例,每日大剂量照射1次,连续4次,最后1次照射后隔48～72小时手术。手术时肿瘤Ⅰ～Ⅱ期者为31.5％,Ⅲ期为68.5％。术后评价,全部住院死亡者不依赖于手术时间,患者出院时仅为相对满意状态,无普外科并发症。术前放疗效果评价,包括术后并发症、病死率、近期和远期疗效。未术前
The experience of surgical treatment of esophageal cancer patients shows that it is impossible to cure with surgical treatment alone, it is difficult to ensure no recurrence and metastasis, and improving the surgical technique and expanding the scope of surgery can not improve the long-term efficacy. This article aims to evaluate the short-term and long-term efficacy of comprehensive treatment of esophageal cancer. The study population consisted of 268 patients undergoing radical surgery for esophageal cancer, including 188 males (70.2%) and 80 females (29.8%), aged 31 to 72 years. 114 patients received preoperative radiotherapy, with a large daily dose of 1 dose, 4 consecutive times, and 48 to 72 hours after the last irradiation. The tumors in stages I-II were 31.5% during operation and 68.5% in stage III. Postoperative evaluation, all in-hospital deaths did not depend on the time of surgery. Patients were only relatively satisfied when they were discharged, and there was no general surgery complication. Assessment of preoperative radiotherapy outcomes, including postoperative complications, mortality, recent and long-term outcomes. Before surgery